William E. Fisher

14.8k total citations
145 papers, 4.7k citations indexed

About

William E. Fisher is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, William E. Fisher has authored 145 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Oncology, 55 papers in Surgery and 33 papers in Molecular Biology. Recurrent topics in William E. Fisher's work include Pancreatic and Hepatic Oncology Research (72 papers), Pancreatitis Pathology and Treatment (33 papers) and Neuroendocrine Tumor Research Advances (22 papers). William E. Fisher is often cited by papers focused on Pancreatic and Hepatic Oncology Research (72 papers), Pancreatitis Pathology and Treatment (33 papers) and Neuroendocrine Tumor Research Advances (22 papers). William E. Fisher collaborates with scholars based in United States, China and Denmark. William E. Fisher's co-authors include F. Charles Brunicardi, Qizhi Yao, Changyi Chen, Somala Mohammed, George Van Buren, Sally E. Hodges, Uddalak Bharadwaj, William J. Schirmer, László G. Boros and Eric J. Silberfein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

William E. Fisher

141 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William E. Fisher United States	41	2.8k	1.6k	1.3k	790	742	145	4.7k
Tetsuji Takayama Japan	37	1.7k 0.6×	2.3k 1.5×	1.3k 1.0×	774 1.0×	1.1k 1.5×	268	6.2k
Andrea Nicolini Italy	38	2.0k 0.7×	1.4k 0.9×	898 0.7×	1.1k 1.4×	751 1.0×	166	5.0k
Fritz Wrba Austria	38	1.6k 0.6×	1.2k 0.8×	1.3k 1.0×	545 0.7×	985 1.3×	167	4.7k
Michio Ogawa Japan	42	1.9k 0.7×	1.3k 0.8×	2.2k 1.7×	550 0.7×	1.0k 1.4×	232	5.6k
Bridget A. Robinson New Zealand	37	2.0k 0.7×	1.3k 0.9×	512 0.4×	711 0.9×	697 0.9×	140	4.4k
Kieran Sheahan Ireland	40	2.9k 1.0×	1.5k 0.9×	1.5k 1.2×	1.1k 1.4×	900 1.2×	175	5.5k
Byoung‐Gie Kim South Korea	45	1.8k 0.6×	1.8k 1.1×	2.1k 1.6×	1.1k 1.4×	688 0.9×	318	7.5k
Kaixiong Tao China	39	1.3k 0.5×	2.4k 1.5×	887 0.7×	1.0k 1.3×	993 1.3×	285	5.2k
Jacintha O’Sullivan Ireland	41	1.7k 0.6×	2.2k 1.4×	787 0.6×	1.2k 1.5×	697 0.9×	171	5.3k
Hemant M. Kocher United Kingdom	46	3.9k 1.4×	2.0k 1.3×	2.0k 1.5×	1.2k 1.5×	1.0k 1.4×	182	6.7k

Countries citing papers authored by William E. Fisher

Since Specialization

Citations

This map shows the geographic impact of William E. Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Fisher more than expected).

Fields of papers citing papers by William E. Fisher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Fisher. The network helps show where William E. Fisher may publish in the future.

Co-authorship network of co-authors of William E. Fisher

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Fisher. A scholar is included among the top collaborators of William E. Fisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Fisher. William E. Fisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yadav, Dhiraj, Dana K. Andersen, Santhi Swaroop Vege, et al.. (2024). Circulating immune signatures in chronic pancreatitis with and without preceding acute pancreatitis: A pilot study. Pancreatology. 24(3). 384–393. 3 indexed citations

Marín‐Müller, Christian, Dali Li, Jianming Lü, et al.. (2023). Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy. Pharmaceutics. 15(8). 2038–2038. 6 indexed citations

Lee, Bomi, Murli Manohar, Liang Li, et al.. (2023). Distinct Serum Immune Profiles Define the Spectrum of Acute and Chronic Pancreatitis From the Multicenter Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) Study. Gastroenterology. 165(1). 173–186. 15 indexed citations

Baust, John M., Robert G. Van Buskirk, Isaac Raijman, et al.. (2022). An In Vitro Investigation into Cryoablation and Adjunctive Cryoablation/Chemotherapy Combination Therapy for the Treatment of Pancreatic Cancer Using the PANC-1 Cell Line. Biomedicines. 10(2). 450–450. 15 indexed citations

Fisher, William E., et al.. (2021). Lactoferrin amyloid presenting as a mural nodule in a pancreatic cystic lesion prompting pancreatoduodenectomy: a case report. BMC Gastroenterology. 21(1). 66–66. 1 indexed citations

King, Mary Etta, Jialing Zhang, John Q. Lin, et al.. (2021). Rapid diagnosis and tumor margin assessment during pancreatic cancer surgery with the MasSpec Pen technology. Proceedings of the National Academy of Sciences. 118(28). 50 indexed citations

Kossatz, Susanne, Sukhen C. Ghosh, Hop S. Tran Cao, et al.. (2019). Specific Targeting of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery. Clinical Cancer Research. 25(14). 4332–4342. 27 indexed citations

Sukumaran, Sujita, Norihiro Watanabe, Pradip Bajgain, et al.. (2018). Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment. Cancer Discovery. 8(8). 972–987. 106 indexed citations

Abbruzzese, James L., Dana K. Andersen, Carl Borrebaeck, et al.. (2018). The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities. Pancreas. 47(5). 516–525. 44 indexed citations

10.

Villafañe-Ferriol, Nicole, Rohan Shah, Somala Mohammed, et al.. (2017). Evidence-Based Management of Drains Following Pancreatic Resection. Pancreas. 47(1). 12–17. 26 indexed citations

11.

Hart, Phil A., Mark Topazian, Massimo Raimondo, et al.. (2016). Endoscopic Pancreas Fluid Collection: Methods and Relevance for Clinical Care and Translational Science. The American Journal of Gastroenterology. 111(9). 1258–1266. 26 indexed citations

12.

Marín‐Müller, Christian, Dali Li, Uddalak Bharadwaj, et al.. (2013). A Tumorigenic Factor Interactome Connected through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer. Clinical Cancer Research. 19(21). 5901–5913. 73 indexed citations

13.

Mohammed, Somala, Charity Evans, George VanBuren, et al.. (2013). Treatment of bacteriobilia decreases wound infection rates after pancreaticoduodenectomy. HPB. 16(6). 592–598. 55 indexed citations

14.

Li, Min, Yu‐Qing Zhang, Uddalak Bharadwaj, et al.. (2009). Down-regulation of ZIP4 by RNA Interference Inhibits Pancreatic Cancer Growth and Increases the Survival of Nude Mice with Pancreatic Cancer Xenografts. Clinical Cancer Research. 15(19). 5993–6001. 86 indexed citations

15.

Li, Min, Uddalak Bharadwaj, Rongxin Zhang, et al.. (2008). Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Molecular Cancer Therapeutics. 7(2). 286–296. 137 indexed citations

16.

Li, Min, Yu‐Qing Zhang, Uddalak Bharadwaj, et al.. (2007). Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proceedings of the National Academy of Sciences. 104(47). 18636–18641. 203 indexed citations

17.

Duerr, Georg Daniel, et al.. (2005). Value of laparoscopy in the staging of pancreatic cancer.. PubMed. 6(6). 552–61. 37 indexed citations

18.

Li, Min, Rongxin Zhang, Fei Li, et al.. (2005). Transfection of SSTR-1 and SSTR-2 Inhibits Panc-1 Cell Proliferation and Renders Panc-1 Cells Responsive to Somatostatin Analogue. Journal of the American College of Surgeons. 201(4). 571–578. 12 indexed citations

19.

Duerr, Georg Daniel, et al.. (2005). Value of laparoscopic in the staging of pancreatic cancer. JOP, journal of the pancreas. 6(6). 552–561. 1 indexed citations

20.

Fisher, William E. & David H. Berger. (2003). Angiogenesis and Antiangiogenic Strategies in Pancreatic Cancer. International Journal of Gastrointestinal Cancer. 33(1). 79–88. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact